Sergio Vázquez, María José Villanueva, José Luis Fírvida, Begoña Campos, Martín Lázaro, Gerardo Huidobro, María del Carmen Areses, Natalia Fernández, Marta Covela, & Joaquín Casal. (2015). Erlotinib as Second-Line Therapy for Patients with Advanced Non-Small-Cell Lung Cancer and Wild-Type EGFR Tumors. Journal of Analytical Oncology, 4(3),  94–101. https://doi.org/10.6000/1927-7229.2015.04.03.1